NCT07602036Not yet recruiting
Type 2 Diabetes and Pregnancy a Single-arm Interventional Study
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
This single-arm interventional study evaluates the MiniMed 780G insulin pump and continuous glucose monitoring (CGM) system in pregnant women with type 2 diabetes enrolled at ≤ 16 weeks gestation. From recruitment to delivery, participants attend regular clinical visits for active insulin adjustments. The primary objective is to measure the percentage of time spent in the target pregnancy glucose range (63-140 mg/dL). Secondary outcomes track mean glucose, HbA1c, and overall maternal and neonatal health to ensure safety and efficacy.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 6 May 2026
- Start date
- 1 May 2026
- Primary completion date
- Oct 2028
- Lead sponsor
- Poznan University of Medical Sciences
- Diseases
- Type 2 diabetes
- NCT number
- NCT07602036
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 1 May 2026 to the primary completion date, Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Pump therapy before pregnancy
Other illness
- Other types of diabetes including T1D and Monogenic diabetes
- Severe nephropathy, psychiatric illness or other serious medical disorder that in the judgment of the investigator could affect completion of the trial
Other
- Major fetal congenital defects
Who the study is looking for
- Women with diagnosed pregestational type 2 diabetes or HbA1c \>6.5% in the 1st trimester (ADA, PTD)
- Age 18-45 years
- Gestational age of 16 weeks +0 days or less at baseline
- Singleton pregnancy
- HbA1c at baseline 5.0-10%
- A viable pregnancy at the recruitment
- Willingness to continue the treatment until delivery in the clinic
Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Heliodor Swiecicki Clinical Gynecology and Obstetrics Hospital of Poznan University of Medical Sciences Coordinator of this site? Confirm its status | Poznan | Poland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.